Investor Stock List
Ranked #4,731 of 8,699 institutional investors

Rosalind Advisors, Inc.

Toronto, A6

$327M
US stock portfolio at live prices · today −$6.1M (−1.82%)
Live prices, last trade 10:25 AM ET
Value at quarter end (Q3 2026)
$309M
Change from Q2 2026
+$43.0M (+16.16%)
Positions
31 · 7 new, 1 sold out
Filed
Nov 16, 2026

Not counted in the ranking: call options on $908K of stock, put options on $1.7M. $29.6M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
DCTH 19.4%XERS 13.2%FENC 12.6%VSTM 8.67%REPL 5.74%
StockSharesValue, live% of portfoliovs Q2 2026
DCTH Delcath Systems, Inc.3,300,389$63.4M19.4%Unchanged
XERS Xeris Biopharma Holdings, Inc.2,582,647$43.3M13.2%Reduced −11%
FENC Fennec Pharmaceuticals Inc.3,188,001$41.2M12.6%Unchanged
VSTM Verastem, Inc.4,236,509$28.3M8.67%Added +6%
REPL Replimune Group, Inc.1,000,000$18.8M5.74%New
SVRA Savara Inc.3,178,121$13.8M4.21%Unchanged
VOR Vor Biopharma Inc.609,199$11.7M3.57%Reduced −6%
XFOR X4 Pharmaceuticals, Inc.3,214,766$9.5M2.92%Unchanged
PCVX Vaxcyte, Inc.149,361$8.6M2.63%Reduced −25%
PEPG PepGen Inc.2,000,000$7.8M2.37%Added +471%
AQST Aquestive Therapeutics, Inc.2,000,000$7.2M2.20%Added +700%
TARA Protara Therapeutics, Inc.2,400,000$5.6M1.70%New
PROF Profound Medical Corp.828,118$5.4M1.66%Unchanged
BCRX BioCryst Pharmaceuticals, Inc.721,504$5.3M1.61%Unchanged
RCKT Rocket Pharmaceuticals, Inc.2,200,000$4.6M1.42%New
MYO Myomo, Inc.3,917,886$3.3M1.02%Added +8%
TLPH Talphera, Inc.4,134,144$3.1M0.95%Reduced −20%
OVID Ovid Therapeutics Inc.1,107,994$2.5M0.76%Unchanged
NSPR InspireMD, Inc.3,905,743$2.4M0.73%Unchanged
NRXS NeurAxis, Inc.548,123$2.4M0.72%Added +8%
CGON CG Oncology, Inc.20,000$1.6M0.50%New
ABVX ABIVAX Société Anonyme20,869$1.5M0.44%Unchanged
AVIR Atea Pharmaceuticals, Inc.280,061$1.1M0.33%Reduced −74%
BFRI Biofrontera Inc.1,789,288$1.1M0.32%Added +40%
SPRB Spruce Biosciences, Inc.26,517$1.0M0.32%Added +33%
FEMY Femasys Inc.759,213$954K0.29%New
GRCE Grace Therapeutics, Inc.476,190$838K0.26%New
KURA Kura Oncology, Inc.100,000$722K0.22%Unchanged
ABOS Acumen Pharmaceuticals, Inc.1,100,000$198K<0.1%New
OKUR OnKure Therapeutics, Inc.67,506$185K<0.1%Reduced −55%
EYPT EyePoint, Inc.695,977$179K<0.1%Reduced −30%

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
CLDX Celldex Therapeutics, Inc.200,000$5.5M